StockData
NRCNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31

NRC HEALTH

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026
$20.47+0.32 (+1.59%)

Close on Oct 19, 2026

Market cap
$450.52M
P/E (TTM)
0.4
Dividend yield
2.54%

Earnings

Next report expected Oct 26, 2026, during market hours (estimated from past report dates)

QuarterReportedTimeRevenueEPS (GAAP)EPS (adjusted)
Q2 FY2026
Ended Jun 30, 2026
Jul 28, 2026During market hours$35.40M$-0.15$0.31
Q1 FY2026
Ended Mar 31, 2026
Apr 28, 2026During market hours$34.80M$0.14$0.21
Q4 FY2025
Ended Dec 31, 2025
Feb 3, 2026Before market open$35.20M$0.08$0.16
Q3 FY2025
Ended Sep 30, 2025
Oct 27, 2025During market hours$34.60M$0.18$0.23
Q2 FY2025
Ended Jun 30, 2025
Jul 28, 2025During market hours$34.04M$-0.01$0.28
Q1 FY2025
Ended Mar 31, 2025
Apr 28, 2025During market hours–––
Q4 FY2024
Ended Dec 31, 2024
Jan 27, 2025During market hours$36.90M$0.28–
Q3 FY2024
Ended Sep 30, 2024
Oct 25, 2024During market hours$35.80M$0.24–
Q2 FY2024
Ended Jun 30, 2024
Aug 6, 2024During market hours–––
Q1 FY2024
Ended Mar 31, 2024
May 7, 2024During market hours–––
Q4 FY2023
Ended Dec 31, 2023
Feb 13, 2024During market hours–––

Press releases

Announcements Nrc Health filed with the SEC